Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation

Adam D. Cohen, David A. Schaer, Cailian Liu et al. · 2010

Read Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation by Adam D. Cohen, David A. Schaer, Cailian Liu et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010436.txt.

Description

Adam Cohen and co-workers used an antibody to rally immunity against melanoma in mice, reporting in PLOS ONE in 2010. A surface switch called GITR can boost T cells that attack tumors. Flipping it had helped anti-tumor immunity before, but the details were murky. Especially unclear was what happens to regulatory T cells, which normally calm attacks. The team gave the antibody to mice with melanoma and watched both cell types.

The treatment changed the stability and location of the regulatory cells inside tumors. With the brakes loosened, killer T cells could work better. Melanoma is a strong test case for immune therapy in mice. Results like these helped pave the way toward human immune treatments. The study clarifies how one switch can retune a tumor's immune balance.

Catalog record

CREATORAdam D. Cohen, David A. Schaer, Cailian Liu et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE55 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010436

Browse the full library · About the Tower of Babel